港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

MIRXES-B

45.820

-0.360-0.78%

成交量：18.66萬

成交額：859.26萬

市值：126.62億

市盈率：-59.58

高：47.000

開：47.000

低：45.020

收：46.180

52周最高：48.700

52周最低：27.050

股本：2.76億

香港流通股本：2.76億

量比：0.35

換手率：0.07%

股息：- -

股息率：- -

每股收益(LYR):-0.769

淨資產收益率：--

總資產收益率：-51.53%

市淨率：-7.79

市盈率(LYR):-59.58

市銷率: 80.05

資料載入中...

總覽公司新聞公告

生物科技公司覓瑞香港上市集資8.8億港元每股售價23.30港元

【IPO追蹤】MIRXES開啓招股，引進復星國際為基石

覓瑞 MIRXES-B啓動招股，5月23日香港上市，復星國際、九江國資委旗下基金參與基石投資

BRIEF-新加坡miRNA技術公司MIRXES香港IPO擬籌10.9億港元，鎖定復星國際等投資者

新股招股 | MIRXES-B今起招股，一手入場費約2353.49港元

老虎资讯综合

MIRXES-B(02629.HK)預計5月23日上市引入北京潯瑞及Evergreen Gate作為基石

新股消息 | 覓瑞集團通過港交所聆訊 miRNA技術開創醫療診斷新篇章

“十八羅漢“之一孫彤宇持股的”癌症早篩公司“覓瑞-B”再遞表，24年收入、毛利雙雙下滑

新股消息 | 覓瑞集團更新招股書核心產品已在新加坡成功商業化

智通财经网

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02629/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02629","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","market":"HK","secType":"STK","nameCN":"MIRXES-B","latestPrice":45.82,"timestamp":1756195697322,"preClose":46.18,"halted":0,"volume":186600,"delay":0,"floatShares":276342331,"shares":276342331,"eps":-0.76899,"marketStatus":"已收盤","change":-0.36,"latestTime":"08-26 16:08:17","open":47,"high":47,"low":45.02,"amount":8592628,"amplitude":0.042876,"askPrice":45.82,"askSize":1500,"bidPrice":45.7,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-0.76899,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1756258200000},"marketStatusCode":5,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":46.18,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.352432,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","floatShares":276342331,"roa":"-51.53%","roe":"--","lyrEps":-0.76899,"volumeRatio":0.352432,"shares":276342331,"dividePrice":0,"high":47,"amplitude":0.042876,"preClose":46.18,"low":45.02,"week52Low":27.05,"pbRate":"-7.79","psRate":"80.05","week52High":48.7,"institutionHeld":0,"latestPrice":45.82,"committee":-0.764706,"eps":-0.76899,"divideRate":0,"volume":186600,"delay":0,"ttmEps":-0.76899,"open":47,"prevYearClose":23.3,"prevWeekClose":45.82,"prevMonthClose":30.55,"prevQuarterClose":34.5,"fiveDayClose":48.36,"twentyDayClose":31,"sixtyDayClose":28.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02629\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02629","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02629\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02629\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02629\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02629","date":"2025-08-25","current":-16.849413,"percent":0.015625,"low":-17.63001,"twenty":-12.493638,"median":-11.382498,"eighty":-10.789519,"high":-10.373055,"avg":-11.989697,"sd":1.72626,"marketCap":12152035222},"quantilePoints":[{"date":"2025-05-30","current":-10.615633,"twenty":-10.820807,"median":-10.729406,"eighty":-10.614136,"marketCap":7683833445},{"date":"2025-06-06","current":-10.752673,"twenty":-10.811558,"median":-10.713624,"eighty":-10.576495,"marketCap":7789091437},{"date":"2025-06-13","current":-10.566273,"twenty":-10.761884,"median":-10.608146,"eighty":-10.555773,"marketCap":7657518947},{"date":"2025-06-20","current":-12.580768,"twenty":-10.923966,"median":-10.686264,"eighty":-10.56693,"marketCap":9117973591},{"date":"2025-06-27","current":-12.5082,"twenty":-12.340962,"median":-10.752673,"eighty":-10.581112,"marketCap":9065344595},{"date":"2025-07-04","current":-11.927039,"twenty":-12.355485,"median":-10.862871,"eighty":-10.586526,"marketCap":8644312625},{"date":"2025-07-11","current":-11.200931,"twenty":-12.261215,"median":-11.092147,"eighty":-10.600008,"marketCap":8118022663},{"date":"2025-07-18","current":-11.402889,"twenty":-12.217621,"median":-11.255392,"eighty":-10.612638,"marketCap":8262752403},{"date":"2025-07-25","current":-11.182791,"twenty":-12.077376,"median":-11.219171,"eighty":-10.651065,"marketCap":8104865414},{"date":"2025-08-01","current":-11.128301,"twenty":-11.949795,"median":-11.200931,"eighty":-10.68858,"marketCap":8065393667},{"date":"2025-08-08","current":-11.930929,"twenty":-11.952128,"median":-11.246394,"eighty":-10.71678,"marketCap":8646944075},{"date":"2025-08-15","current":-16.088166,"twenty":-12.119645,"median":-11.255421,"eighty":-10.743366,"marketCap":11636271059},{"date":"2025-08-22","current":-16.714103,"twenty":-12.435432,"median":-11.355275,"eighty":-10.780307,"marketCap":12057303029},{"date":"2025-08-25","current":-16.849413,"twenty":-12.493638,"median":-11.382498,"eighty":-10.789519,"marketCap":12152035222}],"updateTime":1756184681415},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02629\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535890926","title":"生物科技公司覓瑞香港上市集資8.8億港元 每股售價23.30港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535890926","media":"联合早报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535890926?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 16:41","pubTimestamp":1747298507,"startTime":"0","endTime":"0","summary":"觅瑞公司致力于使疾病筛查诊断解决方案在亚洲关键市场（包括新加坡及中国）触手可及。公司在2019年于新加坡推出的旗舰产品GastroClear，是全球首个用于早期检测胃癌的miRNA血液检测组。它还有两种其他产品已商业化，另有六种产品处于临床前阶段。中国目前是觅瑞的最大市场之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"zaobao_highlight","url":"https://www.zaobao.com/realtime/singapore/story20250515-6373097","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zaobao.com/realtime/singapore/story20250515-6373097","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zaobao_highlight","symbols":["159837","02629"],"gpt_icon":0},{"id":"2535845662","title":"【IPO追蹤】MIRXES開啓招股，引進復星國際為基石","url":"https://stock-news.laohu8.com/highlight/detail?id=2535845662","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535845662?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 15:58","pubTimestamp":1747295929,"startTime":"0","endTime":"0","summary":"历经四次递表后，Mirxes Holding Company Limited（以下简称“Mirxes ”）的闯关之旅终于迎来了好消息！","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202505_1/f4ed334c-f69b-4387-b718-49180b3ef1d3.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202505_1/f4ed334c-f69b-4387-b718-49180b3ef1d3.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/68259eb95a7712b063520ab3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK1230","00656","02629"],"gpt_icon":0},{"id":"2535589822","title":"覓瑞 MIRXES-B啓動招股，5月23日香港上市，復星國際、九江國資委旗下基金參與基石投資","url":"https://stock-news.laohu8.com/highlight/detail?id=2535589822","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535589822?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 12:50","pubTimestamp":1747284600,"startTime":"0","endTime":"0","summary":"　　觅瑞 MIRXES-B，于今日起至下周二招股，预计2025年5月23日在港交所挂牌上市，中金公司、建银国际联席保荐。　　MIRXES，计划全球发售4662万股，其中90%为国际发售、10%为公开发售，无超额配股权。每股发售价23.30港元，每手100股，最多募资约10.86亿港元。　　MIRXES是次IPO招股引入2名基石投资者，合共认购约5792.01万美元的发售股份，其中九江市国资委旗下的北京浔瑞认购5000万美元、复星国际旗下Evergreen Gate认购约792万美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2025-05-15/doc-inewrkfy5168362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1230","02629","00656"],"gpt_icon":0},{"id":"2535839455","title":"BRIEF-新加坡miRNA技術公司MIRXES香港IPO擬籌10.9億港元，鎖定復星國際等投資者","url":"https://stock-news.laohu8.com/highlight/detail?id=2535839455","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535839455?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 09:36","pubTimestamp":1747272996,"startTime":"0","endTime":"0","summary":"BRIEF-新加坡miRNA技术公司MIRXES香港IPO拟筹10.9亿港元，锁定复星国际等投资者路透香港5月15日 - 总部位于新加坡的微小核糖核酸技术公司--Mirxes Holding Company Limited2629.HK：* 计划发售46,620,000股股份，每股发售价23.3港元，预期股份于5月23日开始于联交所买卖* 我们的核心产品GASTROClearTM为一个由12种miRNA生物标志物组成的用于胃癌筛查的基于血液的miRNA检测组* 与北京浔瑞及Evergreen Gate订立基石投资协议，涉资5,792万美元；Evergreen Gate为复星国际0656.HK旗下企业公告全文，请点击此处  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nL4T3RN03F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","02629","00656"],"gpt_icon":0},{"id":"1139796249","title":"新股招股 | MIRXES-B今起招股，一手入場費約2353.49港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139796249","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139796249?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 09:08","pubTimestamp":1747271296,"startTime":"0","endTime":"0","summary":"5月15日，$MIRXES-B$于5月15日-5月20日招股，拟全球发售4662万股，其中香港发售占10%，国际发售占90%;发售价将为每股发售股份23.30港元;每手100股，预期H股将于5月23日在联交所买卖。乙组门槛为25万股，申购所需资金约588.38万港元。集团的核心产品GASTROClearTM为一个由12种miRNA生物标志物组成的用于胃癌筛查的基于血液的miRNA检测组。集团估计，公司全球发售所得款项净额合共将约为8.805亿港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/26d35a88c8d9d9d46abd395d2bd24396","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/26d35a88c8d9d9d46abd395d2bd24396"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股招股 | MIRXES-B今起招股，一手入场费约2353.49港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":1},{"id":"2535884880","title":"MIRXES-B(02629.HK)預計5月23日上市 引入北京潯瑞及Evergreen Gate作為基石","url":"https://stock-news.laohu8.com/highlight/detail?id=2535884880","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535884880?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 06:58","pubTimestamp":1747263481,"startTime":"0","endTime":"0","summary":"格隆汇5月15日丨MIRXES-B发布公告，公司拟全球发售4662万股股份，中国香港发售股份466.2万股，国际发售股份4195.8万股；2025年5月15日至5月20日招股；发售价将为每股发售股份23.30港元，每手买卖单位为100股，中金公司及建银国际为联席保荐人；预期股份将于2025年5月23日开始在联交所买卖。集团的核心产品GASTROClearTM为一个由12种miRNA生物标志物组成的用于胃癌筛查的基于血液的miRNA检测组。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/15065850395627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00656","BK1230","02629"],"gpt_icon":1},{"id":"2534853264","title":"新股消息 | 覓瑞集團通過港交所聆訊 miRNA技術開創醫療診斷新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=2534853264","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534853264?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 11:17","pubTimestamp":1747019842,"startTime":"0","endTime":"0","summary":"招股书显示，觅瑞集团成立于2014年，是一家总部位于新加坡的微小核糖核酸技术公司，致力于使疾病筛查诊断解决方案在亚洲关键市场触手可及。根据弗若斯特沙利文的资料，觅瑞集团的核心产品GASTROClearTM为全球首款也是唯一一款获批准进行胃癌筛查的分子诊断IVD产品。胃癌是2023年全球第五大癌症死亡原因，在2023 年全球所有癌症发病率中排名第五，全球发病人数共约100万人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159891","02629"],"gpt_icon":0},{"id":"2533239919","title":"“十八羅漢“之一孫彤宇持股的”癌症早篩公司“覓瑞-B”再遞表，24年收入、毛利雙雙下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2533239919","media":"财华社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533239919?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 08:59","pubTimestamp":1746665982,"startTime":"0","endTime":"0","summary":"摘要：觅瑞于2025年5月7日向港交所递交招股书，拟在香港主板上市，这是公司第4次递交上市申请，联席保荐人为中金公司和建银国际，公司是一家起源于新加坡的微小核糖核酸（“miRNA”）技术公司，专注于在全球范围内普及疾病筛查诊断解决方案。公司已于今年1月24日通过证监会备案。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202505_1/1b99039b-30bc-481a-bf6f-aa1ba8e61e6c.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202505_1/1b99039b-30bc-481a-bf6f-aa1ba8e61e6c.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/681c01fe5a7712bd1a30350a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK4548","BK4139","02629","LU0266013472.USD","LU2324357040.USD","EXAS","LU1861559042.SGD","LU1861558580.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2533791466","title":"新股消息 | 覓瑞集團更新招股書 核心產品已在新加坡成功商業化","url":"https://stock-news.laohu8.com/highlight/detail?id=2533791466","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533791466?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 16:02","pubTimestamp":1746604947,"startTime":"0","endTime":"0","summary":"据港交所5月7日披露，觅瑞集团(Mirxes Holding Company Limited)向港交所主板递交上市申请","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20250507/20250507160408_72207.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250507/20250507160408_72207.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1920062954.HKD","SG9999003826.SGD","FSTAS.SI","LU2242646235.USD","SG9999014492.USD","BK6033","LU0192582467.USD","LU1119993845.HKD","SG9999001846.SGD","BK6523","S68.SI","FSTM.SI","LU2401740654.USD","SG9999004360.SGD","SGXZ27511609.SGD","LU2242652126.USD","STI.SI","BK6516","LU0898667661.SGD","SG9999016042.SGD","LU1920063259.USD","SG9999000343.SGD","SG9999006266.SGD","02629","LU0877626530.USD","LU0205439572.USD","LU2242646821.SGD","LU0188438112.USD","ES3.SI","SG9999001135.SGD","SG9999014484.SGD","LU0831103253.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":89,"code":"91000000","status":"200"}]}}